Ras-related proteins are 21-to 25 -kDa proteins which bind guanine nucleotides and have GTPase activity. On the basis of their sequence homology, they can be divided into three main subfamilies: Ras, Rho, and Rab (13) . All operate as molecular switches by interacting with different sets of proteins in the inactive GDP-or active GTP-bound state (reviewed in reference 8). Ras-related proteins are involved in regulating a wide range of cellular processes, including cell proliferation, differentiation, intracellular trafficking (7, 24) , membrane ruffling, and assembly of actin stress fibers (43, 44) . Although these proteins serve very diverse functions, their ability to associate with cell membranes is a fundamental requirement for biological activity (review in reference 20) such that mutations in Ras, Rho, and Rab proteins which block membrane localization also render these proteins biologically inactive (2, 21, 40, 49, 51) .
The mechanism of attachment of Ras proteins to the inner surface of the plasma membrane provides a model for the membrane targeting of other Ras-related proteins. The C terminus of Ras terminates in a CAAX motif (C = cysteine, A = aliphatic amino acid, X = any amino acid) which undergoes farnesylation of the cysteine residue (12, 28) , proteolysis by an endopeptidase to remove the AAX amino acids (19, 23) , and carboxyl-methyl esterification of the cysteine (16, 23) . Although these modifications render the C terminus of the protein hydrophobic and thereby facilitate membrane association, additional protein sequences in the adjacent C-terminal hypervariable region are required to target Ras proteins to the plasma membrane. This second * Corresponding author. Mailing address: ONYX Pharmaceuticals, 3031 Research Dr., Richmond, CA 94806. Phone: (510) 222 9700. Fax: (510) 222 9758. signal is a polylysine domain in K-Ras and cysteine palmitoylation sites in the H-and N-Ras proteins. This combination of CAAX motif plus a second signal is also sufficient to target cytosolic heterologous proteins, such as protein A (25) or p120 GTPase-activating protein (GAP) (34) , to the plasma membrane.
It is interesting to note that while Ras proteins are farnesylated, the majority of other Ras-related proteins are geranylgeranylated (reviewed in reference 29). Alkylation with C20 geranylgeranyl occurs on proteins with three different C-terminal motifs; CAAX motifs, where X is a leucine or a phenylalanine, are prenylated by geranylgeranyltransferase I (GGTase I) (11, 41, 47) , and CC and CXC motifs, which are found at the C termini of Rab proteins, are prenylated by GGTase II, also known as Rab geranylgeranyltransferase (32, 45, 46) . Following geranylgeranylation, CAAL/F motifs are AAX proteolysed and methylated. The CXC motif is geranylgeranylated on both cysteines and is also methylated (18, 42) . The stoichiometry of geranylgeranylation of the CC motif is less certain (20, 36, 38, 50) . However, this motif is not methylated (42, 50) . It is reasonable to speculate that there is a single C20 geranylgeranyl group attached to the upstream cysteine, since a carboxy-terminal geranygeranyl cysteine would be a substrate for methylation. The biological significance of these different stoichiometries and different methylation statuses is not known. The famesyltransferase and GGTase I prenylate CAAX or CAAL tetrapeptides in vitro, while the recognition sequence for Rab GGTase II is more complex (35) and may involve Rab sequences remote from the CC and CXC motifs.
Rab proteins are attached to different intracellular membranes and are involved in endocytosis and secretion (9, 48) . The targeting of Rab proteins to specific subcellular locations is determined in part by their C-terminal sequences (14) , but whether these sequences are sufficient to target heterologous proteins to the same locations is unclear, and the role played by geranylgeranylation in Rab localization has not been investigated. An interesting question is whether C15 (farnesol) and C20 (geranylgeranyl) moieties are interchangeable for Rab proteins. Such analysis of Ras has yielded some interesting observations. First, Ras proteins with an X-*L mutation in the CAAX box undergo geranylgeranylation but are still localized to the plasma membrane. However, if the polybasic domain or palmitoylation site is removed, these geranylgeranylated Ras proteins are associated with intracellular membranes and not the plasma membrane (25) . Geranylgeranylated oncogenic Ras proteins are transforming irrespective of their subcellular localization (25) , but low-level expression of plasma membrane-localized geranylgeranylated wild-type Ras is growth inhibitory (17) .
The Rab6 protein is localized in the medial and trans cisternae of the Golgi complex (22) . The C-terminal CSC sequence predicts prenylation with two geranylgeranyl groups followed by methylation. We have constructed Rab6 proteins with a set of alternative C-terminal motifs (CC, CCIL, CKCCIL, CVLS, and CKCVLS) to direct all known combinations of C-terminal lipid modifications. Our results show that farnesylation alone cannot substitute for geranylgeranylation to localize Rab6 to the Golgi complex, demonstrating a significant functional difference between these isoprenoids. However, a combination of farnesylation plus palmitoylation, which localizes heterologous proteins to the plasma membrane, localized Rab6 to the Golgi complex. We conclude that the Rab6 protein contains sequences which can override the plasma membrane-targeting function of this lipid combination and show that while these overriding sequences are contained within the C-terminal hypervariable domain of the protein, the Golgi-targeting sequence is not. A functional analysis of mutant Rab6 proteins in Saccharomyces cerevisiae shows that suppression of the ypt6-phenotype correlates with Golgi localization in mammalian cells and that the C-terminal hypervariable domain of Rab6 is not required for function in yeast cells.
MATERIALS AND METHODS
Constructs. The C-terminal sequences used to construct the mutant Rab6 proteins were synthesized by PCR, using as the templates H-ras CCIL and H-ras CAIL mutant cDNAs, which have CAAX motifs that direct geranylgeranylation (described in reference 25), wild-type H-ras cDNA, and wild-type rab6 cDNA (52) . The PCR primers included novel restriction sites for cloning that did not alter the coding sequence. The PCR products were cloned into pGEM 9Zf(-) (Promega) for sequencing and subsequently cloned in frame into the coding sequence NEN) . The whole lysate was partitioned in Triton X-114, and the detergent-partitioning fraction was immunoprecipitated with anti-Rab6 antibodies. Following sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE), the gel was soaked in Enlightening (NEN) and autoradiographed. The labelled bands were digested with pronase from gel slices that had been excised using the autoradiogram as a guide. Labelled peptides were cleaved with methyl iodide by the method of Casey et al. (12) and analyzed by high-pressure liquid chromatography as previously described (42) .
COS cell expression and Triton X-114 partitioning. COS1 cells were electroporated by a method based on that of Chu et al. (15) . Cells were harvested 72 h after transfection and fractionated as described previously (10) were immunoprecipitated with anti-Rab6 antibodies. Labelled Rab proteins were isolated from SDS-gels and subjected to alkaline hydrolysis as described previously (16, 23) .
Western blotting (immunoblotting). Aqueous and detergent-enriched phases of Triton X-114-partitioned, nonlabelled COS1 cell lysates or equal proportions of S100 and P100 fractions were precipitated with 10% trichloroacetic acid on ice for 1 h. The precipitated proteins were collected by centrifugation, washed three times with 1 ml of cold acetone, dried, and taken up in Laemmli sample buffer (42) . Following SDS-PAGE, the proteins were transferred to nitrocellulose by using a semidry blotting system (Pharmacia). The (42, 50) . We therefore constructed a Rab6 protein with a C1C2 motif in place of the wild-type C1XC2 sequence to compare it with the CAAL mutant and hence address whether methylation of the C terminus has any consequence for localization and function of Rab proteins. The structures of these mutant Rab proteins are summarized in Table 1 , which lists the actual amino acid sequences used in constructing the different C-terminal motifs. It should be noted that only the C-terminal motifs of Rab6 are changed in each case, and therefore all of the mutant proteins contain the complete wild-type Rab6 sequence upstream of the CXC motif. In addition, since Rab6 is expressed at a high level in most mammalian cells (22) , a duplicate set of constructs with N-terminal Myc epitope tags (1) was made to allow discrimination between endogenous and mutant Rab6 proteins during immunolocalization.
Rab6 C-terminal mutants are processed in vitro and in vivo.
We have previously cloned CKCVLS, CKCCIL, CVLS, and CCIL sequences from wild-type Ras and a mutant Ras onto heterologous proteins and confirmed that they are processed as described in Table 1 (25, 34) . However, we wished to verify that the expected processing events would (22) . Figure 1 shows that all of the C-terminal mutant Rab6 proteins were processed in COS1 cells. In each case, 30 to 50% of the labelled Rab protein chases from a slowermigrating, aqueous-partitioning form into a faster-migrating, prenylated, detergent-partitioning form. Interestingly, the RabCC was processed efficiently, showing that Rab6 contains the appropriate additional protein sequences or conformation to permit processing of CC and CXC motifs. A similar result was recently obtained with Rab2 (35) . The extent of processing of the various C-terminal mutant proteins was similar to that of the wild-type protein (Fig. 1) . The extent of processing with CAAX/L motifs on the C terminus of Rab6 was slower, however, than the extent to which these motifs were processed when cloned onto Taken together, these data from a combination of wellvalidated in vitro and in vivo assays are fully consistent with the modifications predicted for each of the mutants in Table  1 . Essentially identical results (not shown) were obtained with the N-terminal Myc-tagged Rab constructs, in agreement with earlier reports that this N-terminal addition does not compromise the posttranslational processing of Rasrelated proteins (1).
Farnesylation alone is insufficient for targeting Rab6 to the Golgi complex. The subcellular distribution of C-terminal mutant Myc-tagged Rab6 proteins was investigated in COS1 cells. Cells were fractionated, and equal proportions of the S100 and P100 fractions were resolved by SDS-PAGE and Western blotted with 9E10, an anti-Myc monoclonal antibody. Figure 2A shows that 50% of the wild-type Rab6 and mutant RabCC proteins were found in the P100 fraction. Some 30% of the RabCCIL protein expressed in COS cells was P100 associated, while the extent of membrane association of the geranylgeranylated, palmitoylated RabCKCCIL protein approached that of the wild type ( Fig. 2A) . By contrast, the RabCVLS mutant fractionated completely in the cytosolic S100 fraction, but 30% of the farnesylated and palmitoylated RabCKCVLS protein bound to cellular mem- branes. Figure 2A also shows that for all of the Rab6 proteins with CAAX/L motifs, two species with different electrophoretic mobilities were found in the S100 fraction. Both partitioned into the aqueous phase of Triton X-114 except with RabCVLS, in which case half of the fast-migrating cytosolic form was detergent partitioning. A fast-migrating hydrophilic form was not observed with the wild-type or the RabCC mutant protein. Figure 2B shows that the fastmigrating hydrophilic form of the RabCCIL, RabCKCCIL, RabCVLS, and RabCKCVLS proteins is clearly apparent 24 h after the cells were pulse-labelled but is not visible after a 6-h cold chase (Fig. 1) . This lower-molecular-weight hydrophilic form may therefore represent either processed Rab which has been deprenylated or, more probably, nonprocessed Rab which has undergone proteolysis. Hrycyna and Clarke (33) recently described a cytosolic carboxypeptidase which specifically recognizes proteins with unprocessed C-terminal CAAX sequences. This or a related enzyme may be responsible for proteolysing the unprocessed Rab proteins which accumulate in the COS1 cells as a result of the slower rate of processing of the CAAX/L motifs when present at the C terminus of Rab6.
We (Fig. 3 ). These results demonstrate that the addition of a Myc epitope at the N terminus does not affect the subcellular localization of Rab6 protein and clearly show that overexpression of Rab6 in MDCK cells does not cause mislocalization by saturating the Golgi complex. A previous report (2) suggesting aberrant localization of overexpressed Rab6 did not take account of the significant amount of nonprocessed protein. Figure 3 also shows that despite different posttranslational modifications, the RabCC, RabCCIL, RabCKCCIL, and RabCKCVLS proteins all appeared to be localized to the Golgi complex. The farnesylated RabCVLS protein, being soluble, was washed out of the cells, although very faint nuclear staining was evident (Fig. 3) . In cells permeabilized after fixation, however, the RabCVLS protein was visible diffusely through the cytoplasm, consistent with its fractionation to S100 fraction ( Fig. 2A) . To exclude the possibility that some of the intracellular staining seen with the mutant proteins was endosomal rather than in the Golgi complex, these experiments were repeated in Swiss 3T3 cells which, unlike MDCK cells, are sensitive to brefeldin A. Treatment with brefeldin A causes the bulk of the Golgi complex to redistribute into the endoplasmic reticulum (38a) . Figure 4b shows that brefeldin A treatment of Swiss 3T3 cells causes complete disappearance of endogenous Rab6 staining. In cells overexpressing Myc-tagged Rab6 (Fig. 4c and d (Fig. 4k and 1) . These data are consistent with the majority of the RabCK-CVLS mutant being Golgi complex localized, although a proportion may be mislocalized to another structure.
Golgi complex-targeting sequences of Rab6 are located outside the C-terminal hypervariable domain. Figures 3 and 4 show that the palmitoylated and farnesylated RabCKCVLS protein was targeted to the Golgi complex. This combination of lipids has been shown previously to function as a plasma membrane-targeting signal both for Ras and for heterologous proteins (25, 34) . One interpretation of these data is that there are domains within Rab6 that prevent palmitoylated, farnesylated Rab6 from localizing to the plasma membrane. Since Chavrier et al. (14) have shown that the C-terminal hypervariable domains of Rab5 and Rab7 are involved in subcellular localization, we investigated whether this domain in Rab6 contains sequences which override the plasma membrane-targeting function of the palmitic acid-prenoid combination. A SpeI restriction site was introduced into H-Ras at amino acid position 144 to correspond with a SpeI site in Rab6 at amino acid 155. These are equivalent residues because Rab6 has an extra 11 amino acids at the N terminus when aligned with Ras. The C-terminal 45 amino acids of Rab6 and H-Ras were then exchanged. This Rabl55-Ras chimeric protein has a C-terminal CKCVLS motif but lacks the Rab6 hypervariable domain. A geranylgeranylated form of the Rab155-Ras chimera was also constructed by replacing the CVLS sequence of Rabl55-Ras with a geranylgeranylated CCIL motif. The chimeric proteins were processed as determined by Triton X-114 phase partitioning, both incorporated label from [3H]palmitic acid, and both were P100 associated (Fig. 5 and data not shown) . Immunofluorescence studies in MDCK cells expressing these chimeric Rabl55-Ras proteins now showed staining of both plasma membrane and Golgi complex (Fig. 6) , consistent with the notion that the Rab6 hypervariable region was preventing plasma membrane localization. To confirm that palmitic acid was responsible for the partial plasma membrane localization of the Rabl55-Ras chimeric protein, we removed the cysteine acylation sites upstream of the C-terminal prenylation motif in the geranylgeranylated Rab155-Ras chimera by introducing serine mutations. These mutations do not interfere with prenylation but block palmitoylation. The geranylgeranylated, nonpalmitoylated Rab155-Ras chimera fractionated in the P100 fraction (Fig. 5) , and immunolocalization in MDCK cells showed it to be exclusively in the Golgi complex (Fig. 6 ), although the staining was less intense and slightly more diffuse than with full-length Rab6 (compare with Fig. 3) . Preliminary experiments in Swiss 3T3 cells suggest that this staining is brefeldin A sensitive. As an additional control, we investigated the localization of a full-length, Myc-tagged H-Ras protein with identical C-terminal modifications to the Golgi complex-localized RabiSSRas chimera with respect to geranylgeranylation and no palmitoylation. This mutant H-Ras protein was P100 associated, but as shown in Fig. 6 , it did not localize to the Golgi complex or plasma membrane. In addition to demonstrating the key role of palmitic acid in plasma membrane targeting, these results suggest that Golgi complex-targeting sequences of Rab6 are located, at least in part, in the N-terminal 155 amino acids.
The effector domain of Rab6 is required for Golgi localization. To further define the N-terminal targeting sequence, we constructed a more extensive series of chimeras in which various amounts of H-Ras sequence were used to replace homologous sequences at the N terminus of the nonpalmitoylated, geranylgeranylated RabiSS-Ras chimera (Fig. 7) .
All of these chimeras were stably expressed and membrane associated when analyzed in COS1 cells, but as summarized in Fig. 7 and the H-Ras geranylgeranylated, nonpalmitoylated control Figure 9C shows that when grown at the permissive temperera d) were fractionated into S100 (S) and P100 (P) fractions, ature, each of the transformed strains expressed a Myche same proportion of each was Western blotted with the tagged Rab protein. The steady-state levels of expression of lyc monoclonal antibody 9E10. All of these proteins bind to all of the mutant proteins were comparable (Fig. 9C ).
oranes.
shown and Fig. 7) . The wild-type CXC C terminus was present in these chimeras, which indicates that the conformation of the mutant proteins was sufficiently close to that of a wild-type Rab protein to allow processing by GGTase II. Interestingly, an analysis of the localization of these proteins in MDCK cells showed that the Rab6 effector domain was essential for Golgi complex targeting. In Fig. 8 , it is clear that Rab-L2Ras and Rab-L2+L3R show very weak or no Golgi complex staining, while Rab-L3Ras shows wild-type Golgi complex staining. All proteins were expressed to the same extent in MDCK cells, as shown by the equivalent staining of cells fixed before permeabilization (Fig. 8) .
Farnesylation alone does not allow Rab6 to complement the yeast ypt6 mutation. The ability of the C-terminal mutant Rab6 proteins to function in vivo was analyzed in yeast cells. The YPT6 gene encodes a Rab6 homolog, and disruption of this gene impairs growth at higher temperatures (31, 47a) . Complementation of this temperature-sensitive growth defect was tested following transformation of a ypt6 null mutant with plasmids which drive expression of either wild-type or C-terminal mutant Rab6 proteins. In a replicaplating assay, expression of the wild-type Rab6 protein restored growth at high temperature, as did expression of the other geranylgeranylated Rab6 proteins RabCC, RabCCIL,
DISCUSSION
The majority of Ras-related proteins terminate in cysteinecontaining C-terminal motifs that direct prenylation with C15 farnesyl or C20 geranylgeranyl. It is striking that whereas Ras is farnesylated, most other Ras-related proteins are geranylgeranylated. The role of farnesylation coupled with a second signal such as palmitoylation or the presence of several basic residues in targeting Ras to the plasma membrane has been well characterized (28, 30) , but the role that geranylgeranylation plays in membrane targeting and the biological function of other Ras-related proteins have not to date been carefully addressed. In this study, we have examined whether geranylgeranylation is absolutely required for the localization and biological function of the Ras-related protein Rab6 and mapped other domains in this protein that are required for its subcellular targeting. By making use of the known recognition sequences of the three characterized prenoid transferases and also the acyltransferase that palmitoylates the Ras proteins, we were able to replace the wild-type doubly geranylgeranylated, methylated C terminus of Rab6 with five different lipid combinations.
Although wild-type Rab6 is prenylated with two geranylgeranyl groups, we found that replacement of one of these geranylgeranyl groups with an acyl group, palmitic acid, did not affect its subcellular localization. Moreover, a single geranylgeranyl group also proved sufficient to localize the RabCCIL protein to the Golgi complex. This Golgi complex localization was unaffected by methylation of the C terminus, since the methylated RabCCIL protein and the nonmethylated RabCC protein were both correctly targeted. Replacement of both geranylgeranyl groups with a single farnesyl moiety, however, rendered Rab6 cytosolic. Interestingly, the combination of palmitoylation plus famesylation restored Rab6 to the Golgi complex. One interpretation of these data is that a minimum degree of hydrophobicity of the C terminus of a Rab protein is required for its membrane association which cannot be provided by an isolated farnesyl group. In support of this hypothesis, it has recently been estimated that the hydrophobicity of geranylgeranyl is an order of magnitude greater than that of either famesyl or palmitoyl (5) . These data correlate with our previous observations that geranylgeranylated Ras proteins bind with significantly higher affinity to cellular membranes than famesylated Ras proteins do and that the avidity of membrane binding of a palmitoylated and famesylated Ras protein is similar to that of a geranylgeranylated protein (25, 30) . Taken together, these data suggest that palmitoylation increases the hydrophobicity of a farnesylated Rab6 C terminus sufficiently to permit membrane binding. It is evident from these experiments that a single geranylgeranyl group is sufficient for the subcellular localization of Rab6, raising the question of whether the second geranylgeranyl moiety present in Rab6 and other CXC-containing Rab proteins serves some other function.
Although Rab proteins are all prenylated with one or two geranylgeranyl groups, they are localized to different subcellular structures. Thus, while lipid modification is required for the membrane binding of Rab proteins, other features are clearly necessary for specific subcellular targeting. In the Ras proteins, these additional sequences comprise a palmitoylation site or a polylysine domain which is located adjacent to the CAAX motif in the C-terminal hypervariable domain. The targeting sequences of other Ras-related proteins have been thought to be similarly situated. Evidence for this has recently been provided by Chavrier et al. (14) , who showed that exchanging the hypervariable domains of Rab5 and Rab7 switched their specific subcellular localization. We found in this study, however, that when the hypervariable domain of Rab6 was replaced with that of a geranylgeranylated, nonpalmitoylated Ras protein, the chimeric protein remained in the Golgi complex. The full-length geranylgeranylated, nonpalmitoylated mutant Ras protein, which provided the C-terminal sequences for this chimera, showed no affinity for the Golgi complex or plasma membrane, in agreement with previous data (25) . However, the VOL. 14, 1994 on The C-terminal motif present, either CCIL or CXC, is given for each chimera. Note that the Ras sequence used to construct these chimeras (indicated by *) has a CCIL C-terminal motif and has had the palmitoylation sites Cys-181 and Cys-184 mutated to Ser to prevent palmitoylation and thus plasma membrane localization of the chimeras. The numbering used refers to Rab6 amino acids; for the homologous amino acid in Ras, subtract 11 from the Rab6 residue number (see text). All of the chimeras have an N-terminal Myc tag. Golgi complex localization was investigated by immunofluorescent staining using the anti-Myc antibody 9E10. All of the localization data are summarized here, and selected confocal images are shown in Fig. 8 . + + +, wild-type Golgi complex staining; +, weak Golgi complex staining (as seen in Fig. 6c). (B) The Rab-L2 Ras, Rab-L3Ras, and Rab-L2+L3Ras proteins have CXC C-terminal motifs and are processed to the same extent as wild-type Rab6 in COS cells (not shown). COS cells expressing these proteins were fractionated into S100 (s) and P100 (p) fractions, and equal proportions of all fractions resolved by SDS-PAGE and immunoblotted with the anti-Myc antibody 9E10. All of these chimeras are extensively membrane bound. subcellular localization of the Rabl55-Ras chimera was critically dependent on the specific C-terminal lipid modification. A palmitic acid moiety with either a farnesyl or geranylgeranyl isoprenoid localized the Rab155-Ras protein both to the plasma membrane and to the Golgi complex. This finding illustrates the critical role of palmitic acid in targeting proteins to the plasma membrane, which has already been demonstrated for Ras and certain heterologous proteins (25, 34) . However, the plasma membrane-targeting effect of palmitic acid was overcome in presence of the C-terminal hypervariable domain of Rab6, since palmitoylated and farnesylated, as well as palmitoylated and geranylgeranylated, forms of Rab6 were found exclusively in the Golgi complex. One explanation for this finding is that the hypervariable domain of Rab6 may enhance the avidity of Golgi complex association by stabilizing the interaction of the N terminus with a Golgi complex receptor protein. The immunofluorescence data are consistent with this view because the Golgi complex staining observed with the nonpalmitoylated and geranylgeranylated Rabl55-Ras chimera was less intense than that seen with full-length Rab6, suggesting that some P100-associated Rabl55-Ras protein was To this end, we used S. cerevisiae as a model system since it contains a gene, YPT6, which is highly homologous to rab6 (31, 47a) . We found that the ability of mutant Rab6 proteins to functionally complement the growth defect at higher temperatures associated with YPT6 deletion correlates directly with the correct targeting of these proteins to the Golgi complex in mammalian cells. Thus, in this assay, farnesylation alone as a C-terminal lipid modification is unable to render the Rab6 protein biologically active. This is the first in vivo demonstration of the relevance of specific prenoid modification to Rab function and also highlights the importance of localization to Rab function. Interestingly, the correlation between correction of temperature-sensitive phenotype and Golgi complex localization extended to the Rab-Ras chimeric proteins which lack the hypervariable domain of Rab6. These data indicate that at least in yeast cells, the hypervariable domain of Rab6 is not required for biological activity. A subtle difference was observed between the methylated RabCCIL and nonmethylated RabCC proteins that were prenylated with a single geranylgeranyl group. While both of these mutant Rab6 proteins localized normally in the Golgi complex and both corrected the temperature-sensitive growth defect in S. cerevisiae, it was clear that yeast cells expressing the methylated protein grew significantly more slowly than those expressing the nonmethylated protein. It is possible that the interaction of Rab6 with a protein essential for biological activity but not for Golgi complex localization may be favored by a negatively charged C terminus in the context of a single geranylgeranyl group. It is worth noting that Rho and Rac proteins that are geranylgeranylated, AAX proteolysed, but nonmethylated after processing in the presence of an inhibitor of methyltransferase bind more extensively to RhoGDI than the fully processed methylated proteins do (27) 
